The neuroactive steroid (NAS) tetrahydrodeoxycorticosterone (THDOC) increases protein kinase C (PKC) mediated phosphorylation of extrasynaptic GABAA receptor (GABAAR) subunits leading to increased surface expression of α4/β3 subunit-containing extrasynaptic GABAARs, leading to a sustained increase in GABAAR tonic current density. Whether other naturally occurring and synthetic NASs share both an allosteric and metabotropic action on GABAARs is unknown. Here, we examine the allosteric and metabotropic properties of allopregnanolone (ALLO), and synthetic NASs SGE-516 and ganaxolone. ALLO, SGE-516, and ganaxolone all allosterically enhanced prototypical synaptic and extrasynaptic recombinant GABAARs. In dentate gyrus granule cells (DGGCs) all three NASs, when applied acutely, allosterically enhanced tonic and phasic GABAergic currents. In separate experiments, slices were exposed to NASs for 15 min, and then transferred to a steroid naïve recording chamber followed by ≥ 30 min wash before tonic currents were measured. A sustained increase in tonic current was observed following exposure to ALLO, or SGE-516 and was prevented by inhibiting PKC with GF 109203X. No increase in tonic current was observed with exposure to ganaxolone. In agreement with the observations of an increased tonic current, the NASs ALLO and SGE-516 increased the phosphorylation and surface expression of the β3 subunit-containing GABAARs. Our studies demonstrate that neuroactive steroids have differential abilities to induce sustained increases in the efficacy of tonic inhibition by promoting GABAAR phosphorylation and membrane trafficking dependent on PKC activity.
GABAR-dependent activation of G protein-gated inwardly rectifying potassium channels (GIRK or K3) provides a well-known source of inhibition in the brain, but the details on how this important inhibitory pathway affects neural circuits are lacking. We used sorting nexin 27 (SNX27), an endosomal adaptor protein that associates with GIRK2c and GIRK3 subunits, to probe the role of GIRK channels in reward circuits. A conditional knockout of SNX27 in both substantia nigra pars compacta and ventral tegmental area (VTA) dopamine neurons leads to markedly smaller GABAR- and dopamine DR-activated GIRK currents, as well as to suprasensitivity to cocaine-induced locomotor sensitization. Expression of the SNX27-insensitive GIRK2a subunit in SNX27-deficient VTA dopamine neurons restored GIRK currents and GABAR-dependent inhibition of spike firing, while also resetting the mouse's sensitivity to cocaine-dependent sensitization. These results establish a link between slow inhibition mediated by GIRK channels in VTA dopamine neurons and cocaine addiction, revealing a therapeutic target for treating addiction.
Fragile X syndrome (FXS) is the most common form of inherited intellectual disability. In addition, there is increased incidence of anxiety, sleep irregularities, and seizure activity. The underlying cause of FXS is a loss of the fragile X mental retardation protein (FMRP) which has been shown to participate in the biosynthesis of δ subunits. Studies from both FXS patients and animal models have revealed reduced expression levels of GABAAR α4 and δ subunits with a reduced efficacy of tonic inhibition. Neurosteroids (NS) are known allosteric modulators of GABAAR channel function but recent studies from our laboratory have revealed that NS also exert persistent effects on the efficacy of tonic inhibition by increasing the PKC‐mediated phosphorylation of the α4 subunit which increases the membrane expression and boosts tonic inhibition. We have used a combination of biochemical and electrophysiological methods to assess alterations in GABAergic signaling in the hippocampus of FMRP knock‐out mouse (Fmr1 KO), a widely validated model of the human syndrome.Our preliminary studies demonstrate that Fmr1 KO mice at p21 have a decrease in phosphorylation of S443 in the α4 subunit compared to WT and an increase in the phosphorylation of β3 subunits at the S408/409 site compared to WT. We have previously showed that phosphorylation of these residues changes the trafficking of the subunits so the changes observed in Fmr1 KO mice would predictably have consequences for trafficking of these essential inhibitory subunits. However, at p48–72 Fmr1 KO mice did not exhibit any deficits in GABAAR expression levels or phosphorylation demonstrating a critical developmental deficit in GABAAR expression. We noted that there was a significant decrease in tonic inhibition in dentate gyrus granule cells in p21 Fmr1 KO mice compared to WT. A 10 min exposure to 1μM THDOC followed by 330 min wash induced a >3 fold increase in tonic current in Fmr1 KO animals which was prevented with PKC inhibition. Using a perforated multi‐electrode array we have observed in horizontal cortical‐hippocampal slices seizure like events (SLE) propagating through the dentate gyrus and into the CA3 and CA1 regions of the hippocampus of Fmr1 KO mice but in WT mice SLEs did not propagate through the dentate gyrus. We predict the increase neuronal excitability seen in Fmr1 KO mice is due to the deficits in tonic inhibition.We have observed that THDOC treatment effectively reversed tonic current deficits in Fmr1 KO mice. Future studies will focus on ameliorating behavioral deficits in Fmr1 KO mice with synthetic neuroactive steroids that display improved pharmacokinetic properties.Support or Funding InformationThis work was supported by grants from the National Institutes of Health (NIH)‐National Institute of Alcoholism and Alcohol Abuse grant AA017938 (P.A.D), NIH‐National Institute of Mental Health grant, MH097446, and DOD, AR140209 (PAD & SJM), NIH‐National Institute of Neurological Disorders and Stroke grant NS051195, NS056359, NS081735, NS080064, NS087662 (SJM), the Simons Foundation #206026 (S.J.M.).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.